Ovarian cancer Flashcards
Proportion of GYN cancer that is ovarian and proportion of GYN cancer deaths that are ovarian.
25% / 50%
Lifetime risk of ovarian cancer for average woman
1:70
Percent of ovarian cancers of each type
Epithelial 85%
Germ cell 10%
Sex cord stromal 5%
Risk factors for ovarian cancer (5)
- Early menarche
- Late menopause
- Ovulation induction agents
- Environmental factors? (talc, asbestos)
- Genetics
Protective factors against ovarian cancer (5)
- OCPs
- Pregnancy
- Breastfeeding
- Tubal ligation
- Hysterectomy
Genetic syndromes related to ovarian cancer (3)
BRCA1, BRCA2, Lynch II
Chromosomes of BRCA mutations
BRCA1 = chromosome 17 BRCA2 = chromosome 13
Risk of ovarian cancer with each BRCA mutation
BRCA1 50%
BRCA2 25%
Risk of breast cancer with each BRCA mutation
BRCA1 60-90%
BRCA2 60-90%, also male breast cancer increased
Mutations of Lynch (HNPCC)
MSH2 or MLH1
Cancers caused by Lynch (HNPCC)
Colon (most common, proximal colon)
Endometrial
Stomach, small intestine, ovary, urinary tract, bile duct, etc.
Only way to make definitive diagnosis of ovarian cancer
Surgical USO
Size concerning for ovarian malignancy pre- and post-menopausal
> 8 cm premenopausal
>5 cm postmenopausal
CA125 concerning in premenopausal woman
> 200
Most common histology of epithelial ovarian cancer
Serous (50-60%)
Endometrioid (20%)
Mucinous (15%)
Clear cell (5%)
FIGO staging of ovarian cancer by location
Stage I - ovary
Stage II - pelvis
Stage III - abdomen and retroperitoneum
Stage IV - distant
Stage I
IA - unilateral IB - bilateral IC1 - surgical spillage IC2 - capsule rupture prior to surgery IC3 - positive washings
Stage II
IIA - tube or uterus
IIB - other pelvic or peritoneal extension
Stage III
IIIA1 - retroperitoneal LNs
IIIA2 - microscopic extrapelvic spread
IIIB - visible but <2 cm
IIIC - >2 cm
Stage IV
IVA - pleural effusion with cytology pos
IVB - parenchymal mets to liver, spleen, or extra-abdominal organs (including inguinal LNs)
Percent of ovarian cancer found stage III-IV
70-80%
Treatment stage IA to IB
Fertility preservation at staging acceptable, no further treatment